<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-106334</identifier>
<setSpec>0214-9168</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Role of serum and glucocorticoid regulated kinase 1 in cardiac alterations induced by aldosterone in rats</dc:title>
<dc:description xml:lang="en">Introduction: Aldosterone induces cardiac hypertrophy and it is known to induce serum and glucocorticoid regulated kinase 1 (SGK-1) gene expression. Aim: We aimed to evaluate structural, functional, in&amp;#64258;ammatory and oxidative alterations, aswell as serum and glucocorticoid regulated kinase1 (SGK-1) expression, produced in rat heartby aldosterone + salt administration. Treatment with spironolactone was evaluated to prove mineralocorticoids mediation. Matherial and methods: Male Wistar rats received aldosterone (1 mg/kg/day) + 1% NaCl for3 weeks. Half of the animals were treated with spironolactone (200 mg/kg/day). At the end of treatment hemodynamics were measured: SBP, DBP, LVEDP, LVSP, +dP/dt and ---dP/dt. Heartrelative weight was measured as cardiac hypertrophy index. mRNA expression of TGF- , CTGF,MMP2, TIMP2, TNF- ,IL-1 , p22phox, eNOS and SGK-1 were measured. Cardiac collagen content was measured by histological techniques. Results: SBP and DBP, LVSP and LVEDP were elevated (P &lt; .05) in aldosterone + salt-treatedrats. ---dP/dt decreased (P &lt; .05) in aldosterone + salt-treated rats, but +dP/dt was similar in all groups. Spironolactone normalized (P &lt; .05) SBP, DBP, LVSP, LVEDP and ---dP/dt. Relative heart weight, collagen content, mRNA expression of TGF- , CTGF, MMP2, TIMP2, TNF- , IL-1 , p22phox, eNOS and SGK-1 were increased (P &lt; .05) in aldosterone + salt-treated rats, being reduced by spironolactone (P &lt; .05).Conlusions: SGK-1 might be a key mediator in the structural, functional and molecular cardiacalterations induced by aldosterone + salt in rats. All the observed changes and mediators are related with activation of mineralocorticoid receptors (AU)</dc:description>
<dc:creator>de las Heras, Natalia</dc:creator>
<dc:creator>Martín-Fernández, Beatriz</dc:creator>
<dc:creator>Cachofeiro, Victoria</dc:creator>
<dc:creator>Valero-Muñoz, María</dc:creator>
<dc:creator>Ballesteros, Sandra</dc:creator>
<dc:creator>Lahera, Vicente</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Introducción: La aldosterona contribuye al desarrollo de la hipertrofia cardiaca. La quinasa regulada por suero y glucocorticoides 1 (SGK-1) desempeña un papel central en el mecanismo de acción de la aldosterona. Objetivo Analizar las alteraciones cardiacas estructurales, funcionales, inflamatorias y oxidativas, así como la expresión del SGK-1, producidas por la administración de aldosterona+sal en ratas. Material y métodos Se utilizaron ratas macho Wistar (250g). Un grupo de animales recibió una dosis diaria de aldosterona 1mg/kg/día subcutánea (s.c.)+NaCl al 1% en el agua de bebida. Otro grupo de animales con hiperaldosteronismo inducido fue tratado con un antagonista de los receptores de mineralocorticoides, la espironolactona (200mg/kg/día, s.c.). Como controles se utilizaron animales a los que se les administró el vehículo (s.c.) y animales a los que se les administró espironolactona (200mg/kg/día, s.c.). El periodo de evolución fue de 21días. Se tomaron las siguientes medidas hemodinámicas: PAS, PAD, FC, pDfVI, PSVI, dP/dt+ y dP/dt&#150;. Como índice de hipertrofia cardiaca se calculó el peso relativo del corazón. Se valoró (..)  (AU)</dc:description>
<dc:source>Clín. investig. arterioscler. (Ed. impr.);24(6): 267-274, nov.-dic. 2012. ilus, tab</dc:source>
<dc:identifier>ibc-106334</dc:identifier>
<dc:title xml:lang="es">Papel de la quinasa regulada por suero y glucocorticoides 1 en las alteraciones cardiacas producidas por la aldosterona en ratas</dc:title>
<dc:subject>^d29611</dc:subject>
<dc:subject>^d9089^s22079</dc:subject>
<dc:subject>^d841</dc:subject>
<dc:subject>^d12345</dc:subject>
<dc:subject>^d6082^s22079</dc:subject>
<dc:subject>^d7426^s22032</dc:subject>
<dc:subject>^d453^s22020</dc:subject>
<dc:subject>^d10967^s22044</dc:subject>
<dc:subject>^d13531^s22079</dc:subject>
<dc:subject>^d30921^s22036</dc:subject>
<dc:subject>^d19167^s22032</dc:subject>
<dc:type>article</dc:type>
<dc:date>201212</dc:date>
</metadata>
</record>
</ibecs-document>
